Skip to main content
Log in

Microwave ablation versus laparoscopic resection for hepatocellular carcinoma in patients with clinically significant portal hypertension: a propensity score–matched study of postoperative liver decompensation

  • Hepatobiliary-Pancreas
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

The study of postoperative liver decompensation after microwave ablation (MWA) for hepatocellular carcinoma (HCC) in patients with clinically significant portal hypertension (CSPH) is still lacking. The purpose of the present study was to compare the postoperative liver decompensation after MWA and laparoscopic resection (LR) for HCC in patients with CSPH.

Methods

The present retrospective study enrolled 222 HCC patients with CSPH who underwent MWA (n = 67) or LR (n = 155). Postoperative liver decompensation, complications, postoperative hospital stays, and overall survival were analyzed. Factors associated with postoperative liver decompensation were identified.

Results

After propensity score matching, the postoperative liver decompensation rate was significantly lower in the MWA group than that in the LR group (15.5% versus 32.8%, p = 0.030). The multivariable regression analysis identified that type of treatment (MWA vs. LR, odds ratio [OR] 0.44; 95% confidence interval [CI], 0.21–0.91; p = 0.026) and Child–Pugh B (OR, 2.86; 95% CI, 1.24–6.61; p = 0.014) were independent predictors for postoperative liver decompensation. The rate of complications for patients in the MWA group was significantly lower than that in the LR group (p < 0.001). And MWA showed shorter postoperative hospital stays than LR (3 days vs. 6 days, p < 0.001). Overall survival rate between the two groups was not significantly different (p = 0.163).

Conclusion

Compared with laparoscopic resection, microwave ablation has a lower rate of postoperative liver decompensation and might be a better option for HCC patients with CSPH.

Clinical relevance statement

Microwave ablation exhibited a lower incidence of postoperative liver decompensation in comparison to laparoscopic resection, thereby conferring greater advantages to hepatocellular carcinoma patients with clinically significant portal hypertension.

Key Points

•Postoperative liver decompensation rate after microwave ablation was lower than that of laparoscopic resection for hepatocellular carcinoma in patients with clinically significant portal hypertension.

•Microwave ablation showed shorter postoperative hospital stays than laparoscopic resection.

•Microwave ablation had fewer complications than laparoscopic resection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

AASLD:

American Association for the Study of Liver Diseases

CSPH:

Clinically significant portal hypertension

HCC:

Hepatocellular carcinoma

IQR:

Interquartile ranges

LR:

Laparoscopic resection

LTP:

Local tumor progression

MELD:

Model for end-stage liver disease

MWA:

Microwave ablation

OS:

Overall survival

PHLF:

Post-hepatectomy liver failure

PLT:

Platelet counts

PSM:

Propensity score matching

References

  1. Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249

    Article  PubMed  Google Scholar 

  2. Craig AJ, von Felden J, Garcia-Lezana T, Sarcognato S, Villanueva A (2020) Tumour evolution in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 17:139–152

    Article  PubMed  Google Scholar 

  3. European Association for the Study of the Liver (2018) EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol 69:182–236

  4. Citterio D, Facciorusso A, Sposito C, Rota R, Bhoori S, Mazzaferro V (2016) Hierarchic interaction of factors associated with liver decompensation after resection for hepatocellular carcinoma. JAMA Surg 151:846–853

    Article  PubMed  Google Scholar 

  5. Berzigotti A, Reig M, Abraldes JG, Bosch J, Bruix J (2015) Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis. Hepatology 61:526–536

    Article  PubMed  Google Scholar 

  6. Berardi G, Morise Z, Sposito C et al (2020) Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis. J Hepatol 72:75–84

    Article  PubMed  Google Scholar 

  7. Gustot T, Stadlbauer V, Laleman W, Alessandria C, Thursz M (2021) Transition to decompensation and acute-on-chronic liver failure: role of predisposing factors and precipitating events. J Hepatol 75(Suppl 1):S36-s48

    Article  PubMed  Google Scholar 

  8. Kokudo T, Hasegawa K, Shirata C et al (2019) Assessment of preoperative liver function for surgical decision making in patients with hepatocellular carcinoma. Liver Cancer 8:447–456

    Article  PubMed  PubMed Central  Google Scholar 

  9. Zheng J, Feng X, Liang Y et al (2021) Safety and feasibility of laparoscopic liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a propensity score-matched study. Surg Endosc 35:3267–3278

    Article  PubMed  Google Scholar 

  10. Heimbach JK, Kulik LM, Finn RS et al (2018) AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 67:358–380

    Article  PubMed  Google Scholar 

  11. Zheng H, Xu C, Wang X et al (2020) Microwave ablation shows similar survival outcomes compared with surgical resection for hepatocellular carcinoma between 3 and 5 cm. Int J Hyperthermia 37:1345–1353

    Article  PubMed  Google Scholar 

  12. Wang Z, Liu M, Zhang DZ et al (2022) Microwave ablation versus laparoscopic resection as first-line therapy for solitary 3-5-cm HCC. Hepatology 76:66–77

    Article  PubMed  Google Scholar 

  13. Liu K, Zheng H, Sui X et al (2022) Microwave ablation versus surgical resection for subcapsular hepatocellular carcinoma: a propensity score-matched study of long-term therapeutic outcomes. Eur Radiol. https://doi.org/10.1007/s00330-022-09135-1

    Article  PubMed  PubMed Central  Google Scholar 

  14. Takayama T, Hasegawa K, Izumi N et al (2022) Surgery versus radiofrequency ablation for small hepatocellular carcinoma: a randomized controlled trial (SURF trial). Liver Cancer 11:209–218

    Article  CAS  PubMed  Google Scholar 

  15. Marrero JA, Kulik LM, Sirlin CB et al (2018) Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 68:723–750

    Article  PubMed  Google Scholar 

  16. Tajiri T, Yoshida H, Obara K et al (2010) General rules for recording endoscopic findings of esophagogastric varices (2nd edition). Dig Endosc 22:1–9

  17. Kim SH, Kim YJ, Lee JM et al (2007) Esophageal varices in patients with cirrhosis: multidetector CT esophagography–comparison with endoscopy. Radiology 242:759–768

    Article  PubMed  Google Scholar 

  18. Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236

    Article  PubMed  Google Scholar 

  19. Faitot F, Allard MA, Pittau G et al (2015) Impact of clinically evident portal hypertension on the course of hepatocellular carcinoma in patients listed for liver transplantation. Hepatology 62:179–187

    Article  PubMed  Google Scholar 

  20. Mathew G, Agha R (2021) STROCSS 2021: strengthening the reporting of cohort, cross-sectional and case-control studies in surgery. Int J Surg 96:106165

    Article  PubMed  Google Scholar 

  21. An C, Cheng Z, Yu X et al (2020) Ultrasound-guided percutaneous microwave ablation of hepatocellular carcinoma in challenging locations: oncologic outcomes and advanced assistive technology. Int J Hyperthermia 37:89–100

    Article  PubMed  Google Scholar 

  22. Urrunaga NH, Singal AG, Cuthbert JA, Rockey DC (2013) Hemorrhagic ascites. Clinical presentation and outcomes in patients with cirrhosis. J Hepatol 58:1113–1118

    Article  PubMed  PubMed Central  Google Scholar 

  23. Liu CH, Arellano RS, Uppot RN, Samir AE, Gervais DA, Mueller PR (2010) Radiofrequency ablation of hepatic tumours: effect of post-ablation margin on local tumour progression. Eur Radiol 20:877–885

    Article  PubMed  Google Scholar 

  24. D’Amico G, Bernardi M, Angeli P (2022) Towards a new definition of decompensated cirrhosis. J Hepatol 76:202–207

    Article  PubMed  Google Scholar 

  25. Rahbari NN, Garden OJ, Padbury R et al (2011) Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149:713–724

    Article  PubMed  Google Scholar 

  26. Ahmed M, Solbiati L, Brace CL et al (2014) Image-guided tumor ablation: standardization of terminology and reporting criteria–a 10-year update. Radiology 273:241–260

    Article  PubMed  Google Scholar 

  27. Vitale A, Peck-Radosavljevic M, Giannini EG et al (2017) Personalized treatment of patients with very early hepatocellular carcinoma. J Hepatol 66:412–423

    Article  PubMed  Google Scholar 

  28. Azoulay D, Ramos E, Casellas-Robert M et al (2021) Liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension. JHEP Rep 3:100190

    Article  PubMed  Google Scholar 

  29. Feng H, Yang C, Xu F et al (2022) Therapeutic efficacy of microwave coagulation versus liver resection for hepatocellular carcinoma within the Milan criteria: a propensity score matching analysis. Eur J Surg Oncol 48:418–424

    Article  PubMed  Google Scholar 

  30. Qiu J, Zheng Y, Shen J et al (2015) Resection versus ablation in hepatitis B virus-related hepatocellular carcinoma patients with portal hypertension: a propensity score matching study. Surgery 158:1235–1243

    Article  PubMed  Google Scholar 

  31. Harada N, Maeda T, Yoshizumi T et al (2016) Laparoscopic liver resection is a feasible treatment for patients with hepatocellular carcinoma and portal hypertension. Anticancer Res 36:3489–3497

    CAS  PubMed  Google Scholar 

Download references

Funding

This work was supported by grants from the National Natural Science Foundation of China (No. 82160124; 82203658; 82100641) and the Study program of Corps science and technology (No. 2022AB024), Project of Science and Technology of Xinjiang Autonomous Region (2022E02044).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Qiang Zhu or Xinya Zhao.

Ethics declarations

Guarantor

The scientific guarantor of this publication is Xinya Zhao.

Conflict of interest

The authors declare no competing interests.

Statistics and biometry

Yes, we enlisted a statistical expert, Xiaoxiao Men, to carefully review the statistical methods utilized throughout this study.

Informed consent

Written informed consent was waived by the institutional review board.

Ethical approval

The study was approved by the ethical committee of Shandong Provincial Hospital.

Study subjects or cohorts overlap

None.

Methodology

• retrospective

• prognostic study

• performed at one institution

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yu, H., Zhao, F., Men, X. et al. Microwave ablation versus laparoscopic resection for hepatocellular carcinoma in patients with clinically significant portal hypertension: a propensity score–matched study of postoperative liver decompensation. Eur Radiol (2023). https://doi.org/10.1007/s00330-023-10268-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00330-023-10268-0

Keywords

Navigation